Dernières nouvelles pour Tegna (NYSE:TGNA) Stock

Tegna

Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.

Tegna Inc

UBS analyst Karl Chalabala maintains Amicus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) with a Buy and raises the price target from $21 to $22.

News

Price Target

Analyst Ratings

FOLD

UBS Maintains Buy on Amicus Therapeutics, Raises Price Target to $22

UBS analyst Peter Grom maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Neutral and raises the price target from $60 to $62.

UBS Maintains Neutral on Estee Lauder Cos, Raises Price Target to $62

UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Buy and raises the price target from $160 to $170.

UBS Maintains Buy on Cardinal Health, Raises Price Target to $170

UBS analyst Kevin Caliendo maintains CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) with a Neutral and raises the price target from $67 to $71.

UBS Maintains Neutral on CVS Health, Raises Price Target to $71

UBS analyst Eliana Merle maintains Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) with a Buy and lowers the price target from $78 to $70.

MRNA

UBS Maintains Buy on Moderna, Lowers Price Target to $70

Casey's General Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASY#NASDAQ">CASY</a>) has outperformed the market over the past 5 years by 9.81% on an annualized basis producing an average annual return of 24.45%. Currently, Casey's General Stores has a market capitalization of $16.70 billion. 
Buying $100 In CASY: If an investor had bought $100 of CASY stock 5 years ago, it would be worth $299.50 today based on a price of $458.65 for CASY at the time of writing.
<h3>Casey's General Stores's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746225012_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CASY

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

UBS analyst Eliana Merle maintains Madrigal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDGL#NASDAQ">MDGL</a>) with a Buy and raises the price target from $441 to $458.

MDGL

UBS Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $458

UBS analyst Joshua Spector maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Neutral and raises the price target from $21 to $22.

UBS Maintains Neutral on Olin, Raises Price Target to $22

UBS analyst Kevin Mcveigh maintains Paylocity Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCTY#NASDAQ">PCTY</a>) with a Neutral and raises the price target from $195 to $200.

PCTY

UBS Maintains Neutral on Paylocity Holding, Raises Price Target to $200

UBS analyst Trung Huynh maintains Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) with a Buy and lowers the price target from $1100 to $1050.

UBS Maintains Buy on Eli Lilly, Lowers Price Target to $1050

UBS analyst Chris Kuntarich maintains Duolingo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) with a Buy and raises the price target from $400 to $500.

DUOL

UBS Maintains Buy on Duolingo, Raises Price Target to $500

UBS analyst Stephen Ju maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Neutral and lowers the price target from $138 to $137.

ABNB

UBS Maintains Neutral on Airbnb, Lowers Price Target to $137

UBS analyst Stephen Ju maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Buy and lowers the price target from $253 to $249.

AMZN

UBS Maintains Buy on Amazon.com, Lowers Price Target to $249

Citigroup analyst Jason Bazinet maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Buy and raises the price target from $78 to $85.

RBLX

Citigroup Maintains Buy on Roblox, Raises Price Target to $85

Citigroup analyst Patrick Donnelly maintains Bio-Rad Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIO#NYSE">BIO</a>) with a Buy and lowers the price target from $400 to $350.

Citigroup Maintains Buy on Bio-Rad Laboratories, Lowers Price Target to $350

Citigroup analyst Ygal Arounian maintains Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Neutral and raises the price target from $30 to $32.

Citigroup Maintains Neutral on Wayfair, Raises Price Target to $32

Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.10) by 160 percent. This is a 116.22 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $79.95 million which beat the analyst consensus estimate of $73.23 million by 9.18 percent. This is a 6.16 percent increase over sales of $75.31 million the same period last year.

Earnings

Earnings Beats

VNCE

CORRECTION: Vince Holding Q4 Adj. EPS $0.06 Beats $(0.10) Estimate, Sales $79.95M Beat $73.23M Estimate

Citigroup analyst Jon Tower maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Buy and raises the price target from $353 to $364.

Citigroup Maintains Buy on McDonald's, Raises Price Target to $364

Citigroup analyst Ronald Josey maintains Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Buy and raises the price target from $150 to $158.

RDDT

Citigroup Maintains Buy on Reddit, Raises Price Target to $158

Citigroup analyst Peter Christiansen maintains Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) with a Buy and lowers the price target from $350 to $270.

Comments

Tegna

Actualités

Dernières nouvelles pour Tegna (NYSE:TGNA) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL